Key result
Pharmacogenetics and genetic variants in drug disposition, targets, or biological systems modulate the variability in response to drugs used for treating sudden cardiac death.
Design
Review
Authors
Loading...
May inform genotype-guided dosing to mitigate drug-related SCD risk; leaves open prospective validation before practice change.
Understanding the genetic basis of variability in drug response provides a framework for managing drug-induced arrhythmias and treating sudden cardiac death.
Dan M. Roden (2001) conducted a review in Drug-induced arrhythmias and sudden cardiac death. Pharmacogenetics and genetic variants in drug disposition, targets, or biological systems modulate the variability in response to drugs used for treating sudden cardiac death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: